Shadri Lab Private Limited is initiating a significant venture with its Active Pharmaceutical Ingredients (API) Unit project in Nakkapalli, Visakhapatnam, Andhra Pradesh. The project entails an investment of 105 Crores, reflecting the company's commitment to expansion and innovation in the pharmaceutical sector.
With a planned production capacity of 450 tonnes per month, the API Unit aims to meet the growing demand for pharmaceutical ingredients. This increased capacity aligns with Shadri Lab's strategic objectives of enhancing market presence and meeting the evolving needs of its clientele.
Nakkapalli in Visakhapatnam, Andhra Pradesh, was chosen as the project location due to its favorable industrial ecosystem, robust infrastructure, and proximity to key transportation networks. These factors provide a conducive environment for efficient project execution and seamless operations.
The API Unit project is poised to generate employment opportunities and stimulate economic growth in the region. Additionally, it will contribute to the development of the local pharmaceutical industry and position Shadri Lab as a key player in the global API market.
Shadri Lab's commitment to quality, compliance, and innovation underscores its vision of delivering high-quality pharmaceutical ingredients that adhere to stringent regulatory standards. The API Unit project represents a significant step towards achieving this vision while driving sustainable growth and value creation for stakeholders.
News by Rahul Yelligetti